| Causes of death among patients with metastatic prostate cancer in the US from 2000 to 2016 AO Elmehrath, AM Afifi, MJ Al-Husseini, AM Saad, N Wilson, KS Shohdy, ... JAMA Network Open 4 (8), e2119568-e2119568, 2021 | 62 | 2021 |
| Safety issues with the ALK inhibitors in the treatment of NSCLC: A systematic review L Kassem, KS Shohdy, S Lasheen, O Abdel-Rahman, A Ali, ... Critical Reviews in Oncology/Hematology 134, 56-64, 2019 | 39 | 2019 |
| Hematological adverse effects in breast cancer patients treated with cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis L Kassem, KS Shohdy, S Lasheen, O Abdel-Rahman, T Bachelot Breast cancer 25, 17-27, 2018 | 39 | 2018 |
| Gastrointestinal adverse effects of cyclin-dependent kinase 4 and 6 inhibitors in breast cancer patients: a systematic review and meta-analysis KS Shohdy, S Lasheen, L Kassem, O Abdel-Rahman Therapeutic Advances in Drug Safety 8 (11), 337-347, 2017 | 32 | 2017 |
| Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis S Lasheen, KS Shohdy, L Kassem, O Abdel-Rahman Expert Review of Anticancer Therapy 17 (9), 851-856, 2017 | 32 | 2017 |
| Common germline-somatic variant interactions in advanced urothelial cancer A Vosoughi, T Zhang, KS Shohdy, PJ Vlachostergios, DC Wilkes, ... Nature Communications 11 (1), 6195, 2020 | 27 | 2020 |
| Abiraterone acetate/androgen deprivation therapy combination versus docetaxel/androgen deprivation therapy combination in advanced hormone-sensitive prostate cancer: a network … L Kassem, KS Shohdy, O Abdel-Rahman Current Medical Research and Opinion 34 (5), 903-910, 2018 | 25 | 2018 |
| Circulating tumor DNA testing—liquid biopsy of a Cancer KS Shohdy, HJ West JAMA oncology 6 (5), 792-792, 2020 | 20 | 2020 |
| Leprosy masquerading as systemic rheumatic diseases H El-Gendy, RM El-Gohary, KS Shohdy, G Ragab JCR: Journal of Clinical Rheumatology 22 (5), 264-271, 2016 | 20 | 2016 |
| MicroRNA as a diagnostic biomarker in childhood acute lymphoblastic leukemia; systematic review, meta-analysis and recommendations WM Rashed, AM Hammad, AM Saad, KS Shohdy Critical reviews in oncology/hematology 136, 70-78, 2019 | 19 | 2019 |
| The emerging treatment options of plasmablastic lymphoma: analysis of 173 individual patient outcomes NF Makady, D Ramzy, R Ghaly, RR Abdel-Malek, KS Shohdy Clinical Lymphoma Myeloma and Leukemia 21 (3), e255-e263, 2021 | 18 | 2021 |
| Serial ctDNA analysis predicts clinical progression in patients with advanced urothelial carcinoma KS Shohdy, DM Villamar, Y Cao, J Trieu, KS Price, R Nagy, ST Tagawa, ... British Journal of Cancer 126 (3), 430-439, 2022 | 17 | 2022 |
| Availability of informal caregivers for palliative care patients with cancer: is there a difference between higher-and lower-income settings R Abdel-Malek, DE Farag, KS Shohdy, S Cox Indian journal of palliative care 25 (3), 379, 2019 | 17 | 2019 |
| Nanoparticles targeting mechanisms in cancer therapy: current limitations and emerging solutions KS Shohdy, AS Alfaar Therapeutic Delivery 4 (9), 1197-1209, 2013 | 15* | 2013 |
| Safety of combination immune checkpoint inhibitors compared to monotherapy; a systematic review and meta-analysis AAM Abdelhafeez, KS Shohdy, W Ibrahim Cancer Investigation 38 (3), 150-157, 2020 | 14 | 2020 |
| Gastric antral vascular ectasia in systemic sclerosis: Where do we stand? H El‐Gendy, KS Shohdy, GG Maghraby, K Abadeer, M Mahmoud International Journal of Rheumatic Diseases 20 (12), 2133-2139, 2017 | 14 | 2017 |
| Risk of pneumonitis with different immune checkpoint inhibitors in NSCLC KS Shohdy, O Abdel-Rahman Annals of Translational Medicine 5 (17), 2017 | 13 | 2017 |
| Alopecia universalis associated with ulcerative colitis and the role of azathioprine KS Shohdy, W Rashad, A Elmeligui Middle East Journal of Digestive Diseases 10 (1), 50, 2018 | 9 | 2018 |
| Lymphodepleting chemotherapy practices and effect on safety and efficacy outcomes in patients with solid tumours undergoing T cell receptor-engineered T cell (TCR-T) Therapy: a … K Owen, R Ghaly, KS Shohdy, F Thistlethwaite Cancer Immunology, Immunotherapy 72 (4), 805-814, 2023 | 8 | 2023 |
| Pathological responses and survival outcomes in patients with locally advanced breast cancer after neoadjuvant chemotherapy: a single-institute experience KS Shohdy, DS Almeldin, MA Fekry, MA Ismail, NA AboElmaaref, ... Journal of the Egyptian National Cancer Institute 33, 1-10, 2021 | 8 | 2021 |
loay kassemLecturer of Clinical oncology, Cairo UniversityVerified email at kasralainy.edu.eg
